CRISPR/Cas9 Shown to Limit Impact of Liver Fluke Infection (IMAGE)

George Washington University

CRISPR/Cas9 Shown to Limit Impact of Liver Fluke Infection

Caption

George Washington University researchers used CRISPR/Cas9 to deactivate the gene that codes for granulin and create parasites that can only produce very little of the protein, leading to markedly reduced symptoms of liver fluke infection.

Credit

GW School of Medicine and Health Sciences

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.